Advertisement

Topics

Why Impax Laboratories Inc Is Up for a Second Straight Day

22:44 EDT 10 Aug 2017 | Topix

Today's move seems to be a continuation of yesterday's jump, perhaps fueled by reports of a Cowen analyst slapping a $20 price target on the stock, which is more than 20% higher than where it closed yesterday. It should be noted that an analyst at the Royal Bank of Canada reportedly has a $17 price target on Impax Laboratories, which doesn't offer much upside.

Original Article: Why Impax Laboratories Inc Is Up for a Second Straight Day

NEXT ARTICLE

More From BioPortfolio on "Why Impax Laboratories Inc Is Up for a Second Straight Day"

Quick Search
Advertisement